Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET
Company Participants
Adam Brown – Senior Vice President-Finance and Investor Relations
Dan Burton – Chief Executive Officer
Bryan Hunt – Chief Financial Officer
Conference Call Participants
Anne Samuel – J.P. Morgan
Jared Haase – William Blair
Elizabeth Anderson – Evercore
Stephanie Davis – SVB Securities
John Ransom – Raymond James
Jessica Tassan – Piper Sandler
Richard Close – Canaccord Genuity
Daniel Grosslight – Citi
Rohan Chandrasekhar – Guggenheim Partners
Operator
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Health Catalyst, Incorporated Second Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode.
After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] At this time, I'd like to turn the conference over to Mr. Adam Brown. Sir, please begin.
Adam Brown
Good afternoon, and welcome to Health Catalyst's earnings conference call for the second quarter of 2022, which ended on June 30, 2022. My name is Adam Brown. I'm the Senior Vice President of Investor Relations and Financial Planning and Analysis for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; and Bryan Hunt, our Chief Financial Officer.
A complete disclosure of our results can be found in our press release issued today, as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com.
As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call.
During today's call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding trends, strategies, the impact of the COVID-19 pandemic and the high inflationary environment on our business and results of operations, our pipeline conversion rates and our general anticipated performance of the business. These forward-looking statements are based on management's current views and expectations as of today and should not be relied upon as representing our views as of any subsequent date.
We disclaim any obligation to update any forward-looking statements or outlook. Actual results may materially differ. Please refer to the risk factors in our Form 10-Q for Q1 2022 filed with the SEC on May 10, 2022, and our Form 10-Q for Q2 2022 that will be filed with the SEC. We will also refer to certain non-GAAP financial measures to provide additional information to investors.